DK3076990T3 - Biologisk aktive insulinderivater - Google Patents

Biologisk aktive insulinderivater Download PDF

Info

Publication number
DK3076990T3
DK3076990T3 DK14833536.7T DK14833536T DK3076990T3 DK 3076990 T3 DK3076990 T3 DK 3076990T3 DK 14833536 T DK14833536 T DK 14833536T DK 3076990 T3 DK3076990 T3 DK 3076990T3
Authority
DK
Denmark
Prior art keywords
biological active
insulin derivatives
active insulin
derivatives
biological
Prior art date
Application number
DK14833536.7T
Other languages
English (en)
Inventor
Kleomenis Barlos
Dimitrios Gatos
Kostas Barlos
Michail Ziovas
Original Assignee
Chemical&Biopharmaceutical Laboratories Of Patras S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical&Biopharmaceutical Laboratories Of Patras S A filed Critical Chemical&Biopharmaceutical Laboratories Of Patras S A
Application granted granted Critical
Publication of DK3076990T3 publication Critical patent/DK3076990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK14833536.7T 2013-12-05 2014-12-04 Biologisk aktive insulinderivater DK3076990T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1321489.5A GB201321489D0 (en) 2013-12-05 2013-12-05 Biologically active insulin derivatives
PCT/IB2014/066588 WO2015083114A2 (en) 2013-12-05 2014-12-04 Biologically active insulin derivatives

Publications (1)

Publication Number Publication Date
DK3076990T3 true DK3076990T3 (da) 2020-03-16

Family

ID=50000217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19208086.9T DK3662926T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater
DK14833536.7T DK3076990T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19208086.9T DK3662926T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Country Status (12)

Country Link
US (1) US10195287B2 (da)
EP (2) EP3662926B1 (da)
JP (1) JP6798883B2 (da)
CN (3) CN118909079A (da)
AU (2) AU2014358699A1 (da)
DK (2) DK3662926T3 (da)
ES (2) ES2965765T3 (da)
GB (1) GB201321489D0 (da)
HK (1) HK1223834A1 (da)
IL (1) IL245983B (da)
PL (1) PL3662926T3 (da)
WO (1) WO2015083114A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
BR112019004314A2 (pt) * 2016-09-06 2019-05-28 Chemical & Biopharmaceutical Laboratories Of Patras S A derivados pró-insulina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847893A (en) * 1972-03-01 1974-11-12 Bayer Ag Process for the preparation of insulin derivatives cross-linked by a dicarboxylic acid group at the amino a-1 glycine and amino b-29 lysine
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK10191D0 (da) 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
WO1995016708A1 (en) 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
IL118127A0 (en) 1995-05-05 1996-09-12 Lilly Co Eli Single chain insulin with high bioactivity
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
DE60104069T2 (de) 2000-10-02 2005-08-25 Yonsei University Einkettige Insulinanaloge
ES2369895T3 (es) * 2003-12-03 2011-12-07 Novo Nordisk A/S Insulina monocatenaria.
US20090036353A1 (en) * 2005-01-27 2009-02-05 Novo Nordisk A/S Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers
EP1863840A1 (en) 2005-03-18 2007-12-12 Novo Nordisk A/S Pegylated single-chain insulin
WO2007096332A1 (en) 2006-02-21 2007-08-30 Novo Nordisk A/S Single-chain insulin analogues and pharmaceutical formulations thereof
EP1996709A2 (en) 2006-03-13 2008-12-03 Novo Nordisk A/S Acylated single chain insulin
EP2074140B8 (en) 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
AU2008288413B2 (en) * 2007-08-15 2013-09-26 Novo Nordisk A/S Insulin analogues with an acyl and aklylene glycol moiety
US8618049B2 (en) * 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin
JP5969469B2 (ja) * 2010-06-16 2016-08-17 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation インスリン受容体に対して高い活性を示す単鎖インスリンアゴニスト
CN104114183A (zh) * 2011-12-20 2014-10-22 印第安纳大学研究及科技有限公司 用于治疗糖尿病的基于ctp的胰岛素类似物
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives

Also Published As

Publication number Publication date
CA2931439A1 (en) 2015-06-11
CN105793283A (zh) 2016-07-20
DK3662926T3 (da) 2023-12-11
PL3662926T3 (pl) 2024-05-13
EP3076990B1 (en) 2020-01-22
WO2015083114A2 (en) 2015-06-11
CN118909080A (zh) 2024-11-08
JP2017501991A (ja) 2017-01-19
IL245983B (en) 2020-03-31
EP3076990A2 (en) 2016-10-12
WO2015083114A3 (en) 2015-11-26
ES2965765T3 (es) 2024-04-16
CN118909079A (zh) 2024-11-08
US20160375146A1 (en) 2016-12-29
US10195287B2 (en) 2019-02-05
EP3662926A1 (en) 2020-06-10
GB201321489D0 (en) 2014-01-22
HK1223834A1 (zh) 2017-08-11
AU2017248496A1 (en) 2017-11-09
IL245983A0 (en) 2016-07-31
JP6798883B2 (ja) 2020-12-09
AU2017248496B2 (en) 2019-08-29
ES2773960T3 (es) 2020-07-15
AU2014358699A1 (en) 2016-06-09
EP3662926B1 (en) 2023-10-25

Similar Documents

Publication Publication Date Title
EP2968894A4 (en) MEDICAL CONNECTOR
DK3679922T3 (da) Sprøjte
DK3685826T3 (da) Sprøjte
EP2832391A4 (en) SYRINGE
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
EP2982401A4 (en) Drug injection syringe
EP2913076A4 (en) SYRINGE
BR112016014772A2 (pt) derivados dihidro-hidantoína com atividade herbicida
DK3662926T3 (da) Biologisk aktive insulinderivater
DE112014002244A5 (de) Infusionslösung
UA25041S (uk) Інжектор медичний
UA28329S (uk) Шприц
PT11257U (pt) Seringa
UA27828S (uk) Спринцівка
TH1401007760A (th) กระบอกฉีดยา
UA28338S (uk) Медичний пристрій-шприц
UA28339S (uk) Медичний пристрій-шприц
TH1401007105A (th) กระบอกฉีดยา (Syringe)
BR302014000168S1 (pt) Configuração aplicada em seringa
EP2885023A4 (en) SYRINGE
FI10036U1 (fi) Potilasalusta
FI10331U1 (fi) Kartiokierreliitos